Search research articles
Contact Us
Filters
Showing results (271-280 of 311) with videos related to
Page
of 32
Sort By:
American Journal of Hematology
|
February 10, 2016
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment
Elizabeth O Hexner, Selina M Luger, Ran Reshef, et al.
Leukemia & Lymphoma
|
February 21, 2022
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide
Craig W Freyer, Alison Carulli, Shannon Gier, et al.
Acta Haematologica
|
September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia
Muhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Haematologica
|
April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
Matthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Transplantation and Cellular Therapy
|
May 9, 2021
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay
Craig W Freyer, Shannon Gier, Mary E Moyer, et al.
Leukemia Research
|
May 29, 2017
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials
Stephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2009
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia
Alexander E Perl, Margaret T Kasner, Donald E Tsai, et al.
Blood
|
May 4, 2013
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia
Courtney D DiNardo, Kathleen J Propert, Alison W Loren, et al.
Transplantation and Cellular Therapy
|
November 6, 2022
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies
Matthew P Connor, Alison W Loren, Elizabeth O Hexner, et al.
Blood Advances
|
January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy era
Xin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 311) with videos related to
Sort By:
Page
of 32
American Journal of Hematology
|
February 10, 2016
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment
Elizabeth O Hexner, Selina M Luger, Ran Reshef, et al.
Leukemia & Lymphoma
|
February 21, 2022
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide
Craig W Freyer, Alison Carulli, Shannon Gier, et al.
Acta Haematologica
|
September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia
Muhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Haematologica
|
April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
Matthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Transplantation and Cellular Therapy
|
May 9, 2021
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay
Craig W Freyer, Shannon Gier, Mary E Moyer, et al.
Leukemia Research
|
May 29, 2017
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials
Stephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2009
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia
Alexander E Perl, Margaret T Kasner, Donald E Tsai, et al.
Blood
|
May 4, 2013
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia
Courtney D DiNardo, Kathleen J Propert, Alison W Loren, et al.
Transplantation and Cellular Therapy
|
November 6, 2022
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies
Matthew P Connor, Alison W Loren, Elizabeth O Hexner, et al.
Blood Advances
|
January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy era
Xin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
Page
of 32